Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma

Journal of Surgical Oncology

Volumn 105, Issue 1, 2012, Pages 85-90

  Wu, Tsung Han ^a   Yu, Ming Chin ^a,b   Chen, Tse Ching ^a   Lee, Chen Fang ^a   Chan, Kun Ming ^a   Wu, Ting Jung ^a,b   Chou, Hong Shiue ^a   Lee, Wei Chen ^a   Chen, Miin Fu ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Encapsulation; Hepatocellular carcinoma; Surgery

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; ENCAPSULATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR ENCAPSULATION; VASCULAR DISEASE;

CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 83455258037     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22060     Document Type: Article

References (33)

1. Poon RT, Fan ST, Lo CM, et al.: Intrahepatic recurrence after curative resection of hepatocellular carcinoma: Long-term results of treatment and prognostic factors. Ann Surg 1999; 229: 216-222. (Pubitemid 30191795)
2. Yanaga K:, Current status of hepatic resection for hepatocellular carcinoma. J Gastroenterol 2004; 39: 919-926. (Pubitemid 39490167)
3. Bruix J, Llovet JM:, Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-524. (Pubitemid 34183954)
4. Yeh CN, Lee WC, Chen MF:, Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10cm: Two decades of experience at Chang Gung memorial hospital. Ann Surg Oncol 2003; 10: 1070-1076. (Pubitemid 40486831)
5. Lee WC, Jeng LB, Chen MF:, Estimation of prognosis after hepatectomy for hepatocellular carcinoma. Br J Surg 2002; 89: 311-316. (Pubitemid 34227029)
6. Kim YS, Rhim H, Cho OK, et al.: Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors. Eur J Radiol 2006; 59: 432-441. (Pubitemid 44301741)
7. Ercolani G, Grazi GL, Ravaioli M, et al.: Liver resection for hepatocellular carcinoma on cirrhosis: Univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 2003; 237: 536-543. (Pubitemid 38176435)
8. Pawlik TM, Delman KA, Vauthey JN, et al.: Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005; 11: 1086-1092. (Pubitemid 41341758)
9. Qin LX, Tang ZY:, The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol 2002; 8: 193-199. (Pubitemid 34414863)
10. el-Assal ON, Yamanoi A, Soda Y, et al.: Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma. Surgery 1997; 122: 571-577. (Pubitemid 27407078)
11. Lai EC, Ng IO, Ng MM, et al.: Long-term results of resection for large hepatocellular carcinoma: A multivariate analysis of clinicopathological features. Hepatology 1990; 11: 815-818. (Pubitemid 20191388)
12. Tanaka T, Yamanaka N, Oriyama T, et al.: Factors regulating tumor pressure in hepatocellular carcinoma and implications for tumor spread. Hepatology 1997; 26: 283-287. (Pubitemid 27328302)
13. Ng IO, Lai EC, Ng MM, et al.: Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 1992; 70: 45-49.
14. Ju MJ, Qiu SJ, Fan J, et al.: Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. Am J Clin Pathol 2009; 131: 498-510.
15. Iguchi T, Aishima S, Taketomi A, et al.: Extracapsular penetration is a new prognostic factor in human hepatocellular carcinoma. Am J Surg Pathol 2008; 32: 1675-1682.
16. Iguchi T, Aishima S, Sanefuji K, et al.: Both fibrous capsule formation and extracapsular penetration are powerful predictors of poor survival in human hepatocellular carcinoma: A histological assessment of 365 patients in Japan. Ann Surg Oncol 2009; 16: 2539-2546.
17. Wu TJ, Wang F, Lin YS, et al.: Right hepatectomy by the anterior method with liver hanging versus conventional approach for large hepatocellular carcinomas. Br J Surg 2010; 97: 1070-1078.
18. Nagao T, Inoue S, Goto S, et al.: Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 1987; 205: 33-40. (Pubitemid 17225020)
19. Paquet KJ, Gad HA, Lazar A, et al.: Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma. Eur J Surg 1998; 164: 513-519. (Pubitemid 28328261)
20. Lockwood DS, Yeadon TM, Clouston AD, et al.: Tumor progression in hepatocellular carcinoma: Relationship with tumor stroma and parenchymal disease. J Gastroenterol Hepatol 2003; 18: 666-672. (Pubitemid 36791704)
21. Grigioni WF, D'Errico A, Biagini G, et al.: The capsule surrounding primary liver tumors: Wherefrom its prognostic significance ? Int J Cancer 1990; 45: 637-643. (Pubitemid 20146121)
22. Ooi LP, Crawford DH, Gotley DC, et al.: Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma. J Hepatol 1997; 26: 798-807. (Pubitemid 27145702)
23. Ishizaki M, Ashida K, Higashi T, et al.: The formation of capsule and septum in human hepatocellular carcinoma. Virchows Arch 2001; 438: 574-580. (Pubitemid 32662376)
24. Hautekeete ML, Geerts A:, The hepatic stellate (Ito) cell: Its role in human liver disease. Virchows Arch 1997; 430: 195-207. (Pubitemid 27151929)
25. Enzan H, Himeno H, Iwamura S, et al.: Alpha-smooth muscle actin-positive perisinusoidal stromal cells in human hepatocellular carcinoma. Hepatology 1994; 19: 895-903.
26. Marra F:, Chemokines in liver inflammation and fibrosis. Front Biosci 2002; 7: d1899-d1914.
27. Aleffi S, Petrai I, Bertolani C, et al.: Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 2005; 42: 1339-1348. (Pubitemid 43260036)
28. Marra F, Delogu W, Petrai I, et al.: Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2004; 287: G18-G26. (Pubitemid 38802114)
29. Pinzani M, Marra F:, Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis 2001; 21: 397-416. (Pubitemid 32923768)
30. Bridle KR, Crawford DH, Powell LW, et al.: Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis. Liver 2001; 21: 96-104. (Pubitemid 32409536)
31. Zavaglia C, De Carlis L, Alberti AB, et al.: Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005; 100: 2708-2716.
32. Chen XP, Qiu FZ, Wu ZD, et al.: Hepatectomy for huge hepatocellular carcinoma in 634 cases. World J Gastroenterol 2006; 12: 4652-4655.
33. Cho YB, Lee KU, Lee HW, et al.: Outcomes of hepatic resection for a single large hepatocellular carcinoma. World J Surg 2007; 31: 795-801. (Pubitemid 46496216)